pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,878 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 149 phase 2 completion · 66 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 0 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: approval×type: phase readout×type: grant×clear all
type
  • phase readout4,876
  • 8k filing2,367
  • earnings286
  • pdufa275
  • phase 2 completion149
  • phase 1 completion66
phase 2 initiation
41
  • phase 1 initiation39
  • phase 1 2 completion31
  • phase 0 trial completion22
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›RECRUITINGphase readoutNCT07615257: Managing Psychological Distress Through Mindfulness-based CBT to Evaluate Its Effectiveness on Self-compassion Among Psoriasis Patients:The Mediating Role of Mental Health Locus of Control

    Sponsor: Islamia University of Bahawalpur. Phase: NA. Conditions: Psoriasis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06087757: Clemastine Treatment in Individuals With Williams Syndrome

    Sponsor: Sheba Medical Center. Phase: PHASE2. Conditions: Williams Syndrome

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05994001: Candonilimab in Combination With LM-302 for Claudin 18.2 Positive-advanced Biliary Tract Cancer After Failure of Standard of Chemotherapy and PD1/PD-L1 Antibody

    Sponsor: Shanghai Zhongshan Hospital. Phase: PHASE1. Conditions: Biliary Tract Cancer, Candonilimab, Claudin 18.2

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06957301: Intrathecal Fentanyl and Dexmedetomidine Added to Bupivacaine for Subarachnoid Anaesthesia for Percutaneous Nephrolithotomy

    Sponsor: Alexandria University. Phase: NA. Conditions: Percutaneous Nephrolithotomy (PCNL)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06533501: Leucine Requirements During the Menstrual Cycle

    Sponsor: University of British Columbia. Phase: NA. Conditions: Menstrual Cycle

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05608681: A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).

    Sponsor: Eupraxia Pharmaceuticals Inc.. Phase: PHASE1. Conditions: Eosinophilic Esophagitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03588481: IRIS- DESyne X2 in the IRIS-DES Registry

    Sponsor: Seung-Jung Park. Phase: . Conditions: Coronary Stenosis, Coronary Occlusion, Coronary Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06558981: Adjuvant Radiotherapy in High Risk Locally Advanced DTC

    Sponsor: Fudan University. Phase: PHASE3. Conditions: Thyroid Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06183281: Integrating Nonpharmacologic Strategies for Pain With Inclusion, Respect, and Equity

    Sponsor: University of California, San Francisco. Phase: NA. Conditions: Chronic Pain

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07647081: The Impacts of Ashwagandha Supplementation on Diurnal Cortisol and Stress Among Women

    Sponsor: Oklahoma State University Center for Health Sciences. Phase: NA. Conditions: Stress

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07470619: Meditation for Chemotherapy-Induced Nausea and Vomiting in Women With Breast Cancer

    Sponsor: Near East University, Turkey. Phase: NA. Conditions: Nausea and Vomiting Chemotherapy-Induced, Meditation Training

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT03730467: Puncture Breast Abscess

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Breast Abscess

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04093167: Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer

    Sponsor: Canadian Cancer Trials Group. Phase: PHASE2. Conditions: Lung Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05235867: Secretin in Refeeding

    Sponsor: University of California, Los Angeles. Phase: . Conditions: Anorexia in Adolescence

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07464067: Family Planning Methods Among Women in Assuit Egypt

    Sponsor: Assiut University. Phase: . Conditions: Family Planning

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03839667: Intensive Diet and Physical Activity on Diabetes

    Sponsor: Shanghai Jiao Tong University School of Medicine. Phase: NA. Conditions: Type2 Diabetes, Life Style

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03439267: Effectiveness of a Proactive Cardiovascular Primary Prevention Strategy, With or Without the Use of Coronary Calcium Screening, in Preventing Future Major Adverse Cardiac Events

    Sponsor: Intermountain Health Care, Inc.. Phase: NA. Conditions: Cardiovascular Primary Prevention Strategy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03144167: Study of Prognostic Biomarkers of Survival at 6 Months for Patients Treated With Bevacizumab Glioblastomas in First Relapse After Failure of Radiochemotherapy

    Sponsor: Centre Hospitalier Universitaire, Amiens. Phase: NA. Conditions: Glioblastoma, Radiotherapy, Chemotherapy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05372367: A Study in People With Advanced Cancer to Test Whether the Amount of BI 907828 in the Blood is Influenced by Taking an OATP Inhibitor or a CYP3 Inhibitor

    Sponsor: Boehringer Ingelheim. Phase: PHASE1. Conditions: Solid Tumors

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03467867: A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL

    Sponsor: Georgetown University. Phase: PHASE2. Conditions: Chronic Lymphocytic Leukemia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06633900: Naltrexone for Overdose Prevention

    Sponsor: University of California, San Francisco. Phase: PHASE2. Conditions: Overdose Accidental

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06611007: Evaluation of the Safety of LipiodolⓇ Embolization in Symptomatic Digital Osteoarthritis Refractory to Conventional Treatment

    Sponsor: University Hospital, Grenoble. Phase: PHASE1. Conditions: Osteoarthritis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06970392: Brief Sleep Intervention for Bedtime Resistance

    Sponsor: Oregon Health and Science University. Phase: NA. Conditions: Child Sleep

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07220720: POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions

    Sponsor: University of Florida. Phase: PHASE2. Conditions: Prostate

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07453420: Profiling Vulnerability and Resilience for Mental Illness Following Viral Infections: Translating Epidemiology to Deep-phenotyping.

    Sponsor: Shalvata Mental Health Center. Phase: . Conditions: Anxiety, Depression - Major Depressive Disorder, Bipolar, Schizophenia Disorder

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07384520: Thrombus Composition in Cerebral Infarctions: Study of Its Association With Plasma Biomarkers, Treatment Efficacy, Etiology and Prognosis.

    Sponsor: François Delvoye. Phase: . Conditions: Ischemic Stroke, Cerebral Veinous Thrombosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06792123: Effect of Virtual Reality Application Applied to Patients With Total Knee Replacement at Different Times

    Sponsor: Özge İşeri. Phase: NA. Conditions: Anxiety, Recovery Quality

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06912659: The BALANCE Study: A Study in Spain to Find Out Whether a Patient Support Program Helps People With Pulmonary Fibrosis Who Take Nintedanib

    Sponsor: Boehringer Ingelheim. Phase: . Conditions: Pulmonary Fibrosis

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT05462262: Intensive Lipid-lowering for Plaque and Major Adverse Cardiovascular Events in Low to Intermediate 10-year ASCVD Risk Population

    Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital. Phase: NA. Conditions: Coronary Artery Disease Progression

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06001346: CBT+ for Depression

    Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: Major Depressive Disorder

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07469488: A Clinical Trial on the Outcomes of Comprehensive Enhanced Prophylaxis Management (CEPM) in Chinese Patients With EGFR-Mutated Advanced NSCLC Receiving Amivantamab-Based Regimens

    Sponsor: Shanghai Pulmonary Hospital, Shanghai, China. Phase: PHASE4. Conditions: NSCLC (Advanced Non-small Cell Lung Cancer), VTE (Venous Thromboembolism), Rash Due to Epidermal Growth Factor Receptor Inhibitors, Infusion Reaction

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07245888: ClusterVAP: Multicentre Proteomic Endotyping of Ventilator-associated Pneumonia

    Sponsor: Region Skane. Phase: . Conditions: Ventilator Acquired Pneumonia, Mechanical Ventilation Complication

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT03211988: Entinostat Neuroendocrine (NE) Tumor

    Sponsor: Antonio Fojo. Phase: PHASE2. Conditions: Neuroendocrine Tumors

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05083403: HPI (Hypotension Prediction Index) Care Trial

    Sponsor: Edwards Lifesciences. Phase: NA. Conditions: Cardiopulmonary Bypass Surgery

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06033027: Arm Use With Soft-robotic Glove

    Sponsor: Roessingh Research and Development. Phase: NA. Conditions: Trauma Injury of Hand Multiple, Neurologic Disorder

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02897427: Throat and Other HPV-Related Cancers in Men: Identifying Them Early

    Sponsor: Baylor College of Medicine. Phase: . Conditions: Human Papillomavirus Infection

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07413627: A Study Evaluating the Contribution of Non-Coplanar Beam Arrangement in Reducing Toxicity in Radiotherapy for Upper Aerodigestive Tract Cancers

    Sponsor: Centre Georges Francois Leclerc. Phase: NA. Conditions: Squamous Cell Carcinoma of the Oral Cavity and Oropharynx

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06070961: Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance

    Sponsor: Fondazione Italiana Linfomi - ETS. Phase: . Conditions: Follicular Lymphoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05933161: A Study of Glycemic Control in Left Ventricular Assist

    Sponsor: Mayo Clinic. Phase: . Conditions: Type 2 Diabetes Mellitus, Hyperglycemia, Hypoglycemia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06008561: Midwest Birth Outcomes and Indigenous American Pregnancy

    Sponsor: Sanford Health. Phase: . Conditions: Pregnancy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04491942: Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

    Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Advanced Bile Duct Carcinoma, Advanced Breast Carcinoma, Advanced Cervical Carcinoma, Advanced Endometrial Carcinoma, Advanced Esophageal Carcinoma, Advanced Gastric Carcinoma, Advanced Head and Neck Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Lung Small Cell Carcinoma, Advanced Malignant Solid Neoplasm, Advanced Ovarian Carcinoma, Advanced Penile Carcinoma, Advanced Pleural Malignant Mesothelioma, Advanced Urothelial Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage IV Gastric Cancer AJCC v8, Stage III Cervical Cancer AJCC v8, Stage III Distal Bile Duct Cancer AJCC v8, Stage III Intrahepatic Bile Duct Cancer AJCC v8, Stage III Lung Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8, Stage III Penile Cancer AJCC v8, Stage III Pleural Diffuse Malignant Mesothelioma AJCC v8, Stage IV Cervical Cancer AJCC v8, Stage IV Distal Bile Duct Cancer AJCC v8, Stage IV Intrahepatic Bile Duct Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IV Penile Cancer AJCC v8, Stage IV Pleural Diffuse Malignant Mesothelioma AJCC v8, Triple-Negative Breast Carcinoma, Unresectable Urothelial Carcinoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06565442: Feasibility of Using NeuraSignal Transcranial Doppler Robot

    Sponsor: University of Alabama at Birmingham. Phase: . Conditions: Cerebral Autoregulation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07542886: A Study to Learn How Different Injector Pens Affect the Study Medicine Called Genotropin (Somatropin) Delivery and Taken up Into the Blood in Healthy Adults

    Sponsor: Pfizer. Phase: PHASE1. Conditions: Healthy

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07227870: L19IL2/TNF in Patients With Basal Cell Carcinoma

    Sponsor: Philogen S.p.A.. Phase: PHASE2. Conditions: Locally Advanced Basal Cell Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07696273: Miniaturized Breath-based Sensor for the Detection of Hypo- and Hyperglycemia

    Sponsor: Indiana University. Phase: NA. Conditions: Diabetes, Hyperglycemia, Hypoglycemia (Diabetic)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07648173: Hybrid HIIT-FES Cycling Program on Individuals With Spinal Cord Injury to Improve Health

    Sponsor: William Carey University. Phase: NA. Conditions: Spinal Cord Injuries

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT02702869: Allied Cleft & Craniofacial Quality-Improvement and Research Network (ACCQUIREnet)

    Sponsor: Duke University. Phase: . Conditions: Cleft Lip, Cleft Palate, Cleft Lip and Palate

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05999773: SGLT-2 Inhibitors in the Treatment of Ascites

    Sponsor: University of Palermo. Phase: . Conditions: Ascites Hepatic, Cirrhosis, Liver, Diabete Type 2

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05388669: A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer

    Sponsor: Janssen Research & Development, LLC. Phase: PHASE3. Conditions: Advanced or Metastatic Non-small Cell Lung Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07071883: Group Activities to Support Addiction Recovery

    Sponsor: University of Nebraska. Phase: NA. Conditions: Addiction, Substance Use Disorders (SUD)

    full page →ctgov ↗
    ← prev
    page 79 of 98
    next →